|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/15/2010 11:40:57 AM
FRANKFURT--(BUSINESS WIRE)--Merz Pharma Group today announced the commencement of its tender offer for all outstanding shares of common stock of BioForm Medical, Inc. (Nasdaq: BFRM) for $5.45 per share, net to the seller in cash, without interest and less any required withholding tax. The tender offer is being made by Vine Acquisition Corp., an indirect wholly-owned subsidiary of Merz GmbH & Co. KGaA (“Merz”), in connection with the Agreement and Plan of Merger among Merz, Vine Acquisition Corp. and BioForm Medical, announced on January 4, 2010, and pursuant to an Offer to Purchase dated January 15, 2010.
|
|
|
|
|
|
|
|
|
|
|